{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:04:58Z","timestamp":1781658298815,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/s10156-012-0519-z","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T21:59:12Z","timestamp":1356040752000},"page":"128-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study"],"prefix":"10.1016","volume":"19","author":[{"given":"Tetsuya","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobu","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yukioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazui","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ichiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Totsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Sunakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-012-0519-z_bib0005","first-page":"676","article-title":"Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man","volume":"47","author":"Totsuka","year":"1994","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-012-0519-z_bib0010","first-page":"705","article-title":"New antimicrobial agent series XL: arbekacin","volume":"44","author":"Niijima","year":"1991","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-012-0519-z_bib0015","unstructured":"Meiji Seika Pharma Co., Ltd. Package insert of Habekacin\u00ae Injection, version 7, 2011."},{"key":"10.1007\/s10156-012-0519-z_bib0020","first-page":"469","article-title":"Study of clinical significance of PK\/PD (pharmacokinetic\/pharmacodynamic) parameters after administering arbekacin to patients with pulmonary methicillin-resistant Staphylococcus aureus infection","volume":"52","author":"Tanikaze","year":"2004","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-012-0519-z_bib0025","first-page":"299","article-title":"An open clinical study of arbekacin 200\u00a0mg q.d. in patients infected with methicillin-resistant Staphylococcus aureus (MRSA)\u2014a clinical pharmacology study","volume":"56","author":"Aikawa","year":"2008","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-012-0519-z_bib0030","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1111\/j.1365-2125.2001.00377.x","article-title":"The therapeutic monitoring of antimicrobial agents","volume":"52","author":"Begg","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1007\/s10156-012-0519-z_bib0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt1977213362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"21","author":"Sawchuk","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1007\/s10156-012-0519-z_bib0040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/AAC.41.5.1115","article-title":"Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing","volume":"41","author":"Demczar","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-012-0519-z_bib0045","first-page":"119","article-title":"Therapeutic drug monitoring survey of anti-MRSA agents in Japan","volume":"58","author":"Kobayashi","year":"2010","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-012-0519-z_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1007\/s10156-012-0519-z_bib0055","first-page":"98","article-title":"Population pharmacokinetic analysis of arbekacin sulfate in adult patients","volume":"27","author":"Sato","year":"2010","journal-title":"Jpn J Ther Drug Monit"},{"key":"10.1007\/s10156-012-0519-z_bib0060","first-page":"597","article-title":"Dose finding study on arbekacin sulfate for appropriate peak levels","volume":"59","author":"Kimura","year":"2011","journal-title":"Jpn J Chemother"},{"issue":"14","key":"10.1007\/s10156-012-0519-z_bib0065","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"10.1007\/s10156-012-0519-z_bib0070","series-title":"The committee for the JRS guidelines in management of respiratory infections: the JRS guidelines for the management of hospital-acquired pneumonia in adults","first-page":"4","year":"2008"},{"key":"10.1007\/s10156-012-0519-z_bib0075","first-page":"55","article-title":"Postmarketing surveillance review of arbekacin sulfate in patients with therapeutic drug monitoring","volume":"27","author":"Kawano","year":"2010","journal-title":"Jpn J Ther Drug Monit"},{"key":"10.1007\/s10156-012-0519-z_bib0080","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s10096-011-1490-9","article-title":"The usefulness of arbekacin compared to vancomycin","volume":"31","author":"Hwang","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-012-0519-z_bib0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-012-0519-z_bib0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10156-012-0397-4","article-title":"The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection","volume":"18","author":"Yamamoto","year":"2012","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10156-012-0519-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:50:31Z","timestamp":1761159031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X13701909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1341321X13701909"],"URL":"https:\/\/doi.org\/10.1007\/s10156-012-0519-z","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-012-0519-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}